Candel Therapeutics, Inc. has filed an 8-K form detailing its financial results and operations as of March 12, 2026. The filing includes Item 2.02, which discusses the results of operations and financial condition.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.